FRNK PROTEINS IN THE TREATMENT OF TUMOR CELLS
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 27, 2001
app pub date -
Dec 2, 1998
filing date -
Dec 3, 1997
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Abstract
A recombinant virus vector comprising a heterologous nucleic acid segment encoding FRNK protein (including active fragments thereof) operably linked to regulatory sequences directing expression of said FRNK protein in a cell susceptible to infection by said DNA virus vector is disclosed. Also disclosed is isolated mammalian FRNK protein, along with nucleic acids encoding the same and expression cassettes containing such nucleic acids. Methods of using the foregoing to induce the death of tumor cells are disclosed.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully